In an era defined by an abundance of information, and new ways to find it, Cochrane’s Chief Executive Officer, Karla Soares-Weiser argues that systematic reviews remain an essential tool to help individuals, healthcare professionals and policymakers make decisions. However, the challenge is no longer simply producing reliable evidence but maintaining the trust that makes Cochrane’s evidence useful.

Knowledge translation (KT) is a key part of ensuring that high-quality evidence reaches the people who can use it. In Italy, however, research methods and evidence-based medicine (EBM) are not consistently integrated into higher education or medical education programmes.

Cochrane has introduced word limits for our reviews, updates, and protocols, to help keep our evidence focused, concise, and more accessible for readers.

Today an international coalition of organizations dedicated to evidence-informed decision-making launched the World Evidence-based Healthcare Day 2026 campaign, ‘Evidence and AI: People at the Centre’.

Cochrane has started rolling out a refreshed toolkit of author training materials. The toolkit provides ready-to-use materials for trainers to deliver or adapt for their own face-to-face and online training.

Following a busy week at the 79th World Health Assembly (WHA), we’re reflecting on the inspiring conversations and high-level discussions Cochrane had the privilege of being involved in.

From searching and screening to drafting text, artificial intelligence (AI) tools offer the promise of increased efficiency. But with promise comes responsibility. Ella Flemyng, Cochrane’s Head of Editorial Policy and Research Integrity, highlights what you need to consider when deciding whether to use an AI tool, and when you might decide not to.

We are looking for a new author team to update a key review on over-the-counter medicines for acute cough. The Cochrane review incorporates evidence from 1966 up to 2012 and a new search for recently published evidence is necessary. Take a look at the requirements, the support we can offer and information on how to register your interest.

As part of our commitment to the highest standards of evidence, Cochrane is strengthening how it identifies and manages retracted publications associated with studies included in published or ongoing Cochrane reviews. This includes new steps to manage retractions of included studies that occur after reviews have been published.

Cochrane has always aimed to provide the right evidence at the right time. As we move into a more collaborative and AI-enabled era, delivering this goal will increasingly rely on structured data. Gert van Valkenhoef, Cochrane’s Head of Data, sets out why we are improving Cochrane’s approach to data, the difference this could make, and what this means for our authors.

Researchers from Trinity College Dublin, St James’s Hospital, and collaborating institutions have carried out the most comprehensive review to date of tools used to estimate breast cancer risk in women with a family history of the disease.

Planned early birth for pregnant women with high blood pressure cuts maternal complications by nearly half and reduces the risk of stillbirth, without increasing the likelihood of caesarean section, according to a new Cochrane review.

Discover the role Cochrane Thailand has played in closing the gap between evidence and outcomes. Designated as a WHO Collaborating Centre for Research Synthesis in Reproductive Health, the group has not only generated Cochrane reviews but has also translated those findings into national policy and clinical guidelines.

Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated Cochrane review finds. This is a shift from the previous version of the review.

Cochrane has released a pre-print of the protocol for our innovative study that will test whether artificial intelligence (AI) tools can support or enhance evidence synthesis. Gerald Gartlehner from Cochrane Austria, Principal Investigator for the study, discusses how the study works, and what makes it interesting.

Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing the risk of bleeding and swelling in the brain, a new Cochrane review has found.

We seek nominations for one upcoming vacant position on the Cochrane Methods Executive, to start in September 2026. Please note the deadline for nominations is Friday, 29 May 2026.

Image Members of Cochrane Russia at a workshop in Kazan When Cochrane Russia was established in 2015, it began as a coordinating hub fo

A new Cochrane review finds that chlorhexidine likely cuts umbilical cord infection rates by about 29% in low- and middle- income countries, and may reduce newborn deaths.

The Cochrane Collaboration is delighted to announce that Rupa Sarkar starts today as the new Editor in Chief.